These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 8977755

  • 21. Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy.
    Dören M, Rübig A, Coelingh Bennink HJ, Holzgreve W.
    Fertil Steril; 2001 Mar; 75(3):554-9. PubMed ID: 11239541
    [Abstract] [Full Text] [Related]

  • 22. Reproductive hormone levels in gynecologic oncology patients undergoing surgical castration after spontaneous menopause.
    Hughes CL, Wall LL, Creasman WT.
    Gynecol Oncol; 1991 Jan; 40(1):42-5. PubMed ID: 1824939
    [Abstract] [Full Text] [Related]

  • 23. Hyperandrogenism in women with polycystic ovary syndrome persists after menopause.
    Markopoulos MC, Rizos D, Valsamakis G, Deligeoroglou E, Grigoriou O, Chrousos GP, Creatsas G, Mastorakos G.
    J Clin Endocrinol Metab; 2011 Mar; 96(3):623-31. PubMed ID: 21177795
    [Abstract] [Full Text] [Related]

  • 24. Endocrine evaluation of patients with benign lumps of the breast.
    Mancini A, di Pietro C, de Marinis L, Rossi S, Lombardi CP, Iacona T, Bellantone R, Liberale I, Menini E, Crucitti F.
    Cancer Detect Prev; 1992 Mar; 16(1):27-30. PubMed ID: 1532347
    [Abstract] [Full Text] [Related]

  • 25. Associations of LH and FSH with reproductive hormones depending on each stage of the menopausal transition.
    Kawakita T, Yasui T, Yoshida K, Matsui S, Iwasa T.
    BMC Womens Health; 2023 May 25; 23(1):286. PubMed ID: 37231423
    [Abstract] [Full Text] [Related]

  • 26. Hypoandrogenism in association with diminished functional ovarian reserve.
    Gleicher N, Kim A, Weghofer A, Kushnir VA, Shohat-Tal A, Lazzaroni E, Lee HJ, Barad DH.
    Hum Reprod; 2013 Apr 25; 28(4):1084-91. PubMed ID: 23427231
    [Abstract] [Full Text] [Related]

  • 27. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease.
    Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD.
    J Clin Endocrinol Metab; 1991 Oct 25; 73(4):811-7. PubMed ID: 1909705
    [Abstract] [Full Text] [Related]

  • 28. Effect of postmenopausal estrogen replacement on circulating androgens.
    Casson PR, Elkind-Hirsch KE, Buster JE, Hornsby PJ, Carson SA, Snabes MC.
    Obstet Gynecol; 1997 Dec 25; 90(6):995-8. PubMed ID: 9397118
    [Abstract] [Full Text] [Related]

  • 29. Ovarian and peripheral plasma levels of progestogens, androgens and oestrogens in post-menopausal women.
    Lucisano A, Acampora MG, Russo N, Maniccia E, Montemurro A, Dell'Acqua S.
    Maturitas; 1984 Jul 25; 6(1):45-53. PubMed ID: 6472127
    [Abstract] [Full Text] [Related]

  • 30. Influence of some biological indexes on sex hormone-binding globulin and androgen levels in aging or obese males.
    Vermeulen A, Kaufman JM, Giagulli VA.
    J Clin Endocrinol Metab; 1996 May 25; 81(5):1821-6. PubMed ID: 8626841
    [Abstract] [Full Text] [Related]

  • 31. Hormonal reproductive status of women at menopausal transition compared to that observed in a group of midreproductive-aged women.
    Sengos C, Iatrakis G, Andreakos C, Xygakis A, Papapetrou P.
    Clin Exp Obstet Gynecol; 2000 May 25; 27(1):54-6. PubMed ID: 10758802
    [Abstract] [Full Text] [Related]

  • 32. Correlation between the Aging Males' Symptoms Scale and sex steroids, gonadotropins, dehydroepiandrosterone sulfate, and growth hormone levels in ambulatory men.
    Miwa Y, Kaneda T, Yokoyama O.
    J Sex Med; 2006 Jul 25; 3(4):723-726. PubMed ID: 16839329
    [Abstract] [Full Text] [Related]

  • 33. Plasma C19 steroid sulphate levels and indices of androgen bioavailability in female pattern androgenic alopecia.
    Montalto J, Whorwood CB, Funder JW, Yong AB, Callan A, Davies HE, Connelly JF.
    Clin Endocrinol (Oxf); 1990 Jan 25; 32(1):1-12. PubMed ID: 2139595
    [Abstract] [Full Text] [Related]

  • 34. Hormonal profiles after the menopause.
    Chakravarti S, Collins WP, Forecast JD, Newton JR, Oram DH, Studd JW.
    Br Med J; 1976 Oct 02; 2(6039):784-7. PubMed ID: 974609
    [Abstract] [Full Text] [Related]

  • 35. A prospective long-term study in women from pre-menopause to post-menopause: changing profiles of gonadotrophins, oestrogens and androgens.
    Rannevik G, Carlström K, Jeppsson S, Bjerre B, Svanberg L.
    Maturitas; 1986 Dec 02; 8(4):297-307. PubMed ID: 2952867
    [Abstract] [Full Text] [Related]

  • 36. Androgen suppressive effect of GnRH agonist in ovarian hyperthecosis and virilizing tumours.
    Pascale MM, Pugeat M, Roberts M, Rousset H, Déchaud H, Dutrieux-Berger N, Tourniaire J.
    Clin Endocrinol (Oxf); 1994 Nov 02; 41(5):571-6. PubMed ID: 7828344
    [Abstract] [Full Text] [Related]

  • 37. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men.
    Field AE, Colditz GA, Willett WC, Longcope C, McKinlay JB.
    J Clin Endocrinol Metab; 1994 Nov 02; 79(5):1310-6. PubMed ID: 7962322
    [Abstract] [Full Text] [Related]

  • 38. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K, Erkkola R, Kaihola HL, Santti R, Irjala K.
    Acta Obstet Gynecol Scand; 1985 Nov 02; 64(8):629-33. PubMed ID: 2938400
    [Abstract] [Full Text] [Related]

  • 39. Cigarette smoking and levels of adrenal androgens in postmenopausal women.
    Khaw KT, Tazuke S, Barrett-Connor E.
    N Engl J Med; 1988 Jun 30; 318(26):1705-9. PubMed ID: 2967432
    [Abstract] [Full Text] [Related]

  • 40. Ovarian and adrenal contributions to peripheral steroid levels in postmenopausal women.
    Maroulis GB, Abraham GE.
    Obstet Gynecol; 1976 Aug 30; 48(2):150-4. PubMed ID: 133306
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.